Annual EBITDA
-$58.31 M
-$11.53 M-24.65%
31 December 2023
Summary:
TriSalus Life Sciences annual earnings before interest, taxes, depreciation & amortization is currently -$58.31 million, with the most recent change of -$11.53 million (-24.65%) on 31 December 2023. TLSI annual EBITDA is now -119.07% below its all-time high of -$26.62 million, reached on 31 December 2021.TLSI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.09 M
+$2.16 M+66.47%
30 September 2024
Summary:
TriSalus Life Sciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.09 million, with the most recent change of +$2.16 million (+66.47%) on 30 September 2024. Over the past year, it has increased by +$174.00 thousand (+13.75%). TLSI quarterly EBITDA is now at all-time high.TLSI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$52.47 M
+$174.00 K+0.33%
30 September 2024
Summary:
TriSalus Life Sciences TTM earnings before interest, taxes, depreciation & amortization is currently -$52.47 million, with the most recent change of +$174.00 thousand (+0.33%) on 30 September 2024. Over the past year, it has dropped by -$6.78 million (-14.83%). TLSI TTM EBITDA is now -590.55% below its all-time high of -$7.60 million, reached on 01 March 2022.TLSI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLSI EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.6% | +13.8% | -14.8% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
TLSI EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -119.1% | at low | at high | +96.9% | -590.5% | +17.0% |
| 5 y | 5 years | -119.1% | at low | at high | +96.9% | -590.5% | +17.0% |
| alltime | all time | -119.1% | at low | at high | +96.9% | -590.5% | +17.0% |
TriSalus Life Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.09 M(-66.5%) | -$52.47 M(-0.3%) |
| June 2024 | - | -$3.25 M(-75.0%) | -$52.64 M(-16.7%) |
| Mar 2024 | - | -$13.03 M(-62.9%) | -$63.20 M(+8.5%) |
| Dec 2023 | -$58.31 M | -$35.10 M(+2674.5%) | -$58.25 M(+27.5%) |
| Sept 2023 | - | -$1.26 M(-90.8%) | -$45.69 M(-13.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$13.81 M(+70.8%) | -$52.52 M(+35.7%) |
| Mar 2023 | - | -$8.08 M(-64.1%) | -$38.71 M(+1.3%) |
| Dec 2022 | -$46.78 M(+75.7%) | -$22.54 M(+178.5%) | -$38.23 M(+143.6%) |
| Sept 2022 | - | -$8.09 M(+6.5%) | -$15.69 M(+106.5%) |
| Mar 2022 | - | -$7.60 M | -$7.60 M |
| Dec 2021 | -$26.62 M | - | - |
FAQ
- What is TriSalus Life Sciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for TriSalus Life Sciences?
- What is TriSalus Life Sciences annual EBITDA year-on-year change?
- What is TriSalus Life Sciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for TriSalus Life Sciences?
- What is TriSalus Life Sciences quarterly EBITDA year-on-year change?
- What is TriSalus Life Sciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for TriSalus Life Sciences?
- What is TriSalus Life Sciences TTM EBITDA year-on-year change?
What is TriSalus Life Sciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TLSI is -$58.31 M
What is the all time high annual EBITDA for TriSalus Life Sciences?
TriSalus Life Sciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$26.62 M
What is TriSalus Life Sciences annual EBITDA year-on-year change?
Over the past year, TLSI annual earnings before interest, taxes, depreciation & amortization has changed by -$11.53 M (-24.65%)
What is TriSalus Life Sciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TLSI is -$1.09 M
What is the all time high quarterly EBITDA for TriSalus Life Sciences?
TriSalus Life Sciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.09 M
What is TriSalus Life Sciences quarterly EBITDA year-on-year change?
Over the past year, TLSI quarterly earnings before interest, taxes, depreciation & amortization has changed by +$174.00 K (+13.75%)
What is TriSalus Life Sciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TLSI is -$52.47 M
What is the all time high TTM EBITDA for TriSalus Life Sciences?
TriSalus Life Sciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$7.60 M
What is TriSalus Life Sciences TTM EBITDA year-on-year change?
Over the past year, TLSI TTM earnings before interest, taxes, depreciation & amortization has changed by -$6.78 M (-14.83%)